Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:09:03 GMT 2023
by
admin
on
Sat Dec 16 14:09:03 GMT 2023
|
| Protein Sub Type | IGE |
| Sequence Origin | HUMAN |
| Sequence Type | INCOMPLETE |
| Record UNII |
AF59OKU9U8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
AF59OKU9U8
Created by
admin on Sat Dec 16 14:09:04 GMT 2023 , Edited by admin on Sat Dec 16 14:09:04 GMT 2023
|
PRIMARY | |||
|
P01854
Created by
admin on Sat Dec 16 14:09:04 GMT 2023 , Edited by admin on Sat Dec 16 14:09:04 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_14 | 2_14 |
| 1_15 | 1_101 |
| 1_29 | 1_83 |
| 1_117 | 2_117 |
| 1_130 | 1_188 |
| 1_204 | 2_204 |
| 1_234 | 1_294 |
| 1_340 | 1_400 |
| 2_15 | 2_101 |
| 2_29 | 2_83 |
| 2_130 | 2_188 |
| 2_234 | 2_294 |
| 2_340 | 2_400 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_21 |
| N | 1_49 |
| N | 1_95 |
| N | 1_141 |
| N | 1_247 |
| N | 1_259 |
| N | 1_270 |
| N | 2_21 |
| N | 2_49 |
| N | 2_95 |
| N | 2_141 |
| N | 2_247 |
| N | 2_259 |
| N | 2_270 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
Omalizumab inhibits the binding of IgE to FcεRI on mast cells and basophils by binding to an antigenic epitope on IgE that overlaps with the site to which FcεRI binds.
BINDING
|
||
|
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
||
|
BINDER->LIGAND | |||
|
|
LIGAND->TARGET |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|